A Look at The Future: Biologic Therapies in Atopic Dermatitis
Dr. Lisa Beck looks at biologics for atopic dermatitis to explain the differences between targeting the IL-13 cytokine and IL-4Rα.
Date of Last Review: May 30, 2024
Document Number: VV-MED-153971
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice